What is the intrinsic value of PMCB?
As of 2025-05-18, the Intrinsic Value of PharmaCyte Biotech Inc (PMCB) is
58.82 USD. This PMCB valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.06 USD, the upside of PharmaCyte Biotech Inc is
5,448.77%.
Is PMCB undervalued or overvalued?
Based on its market price of 1.06 USD and our intrinsic valuation, PharmaCyte Biotech Inc (PMCB) is undervalued by 5,448.77%.
58.82 USD
Intrinsic Value
PMCB Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
58.82 - 58.82 |
58.82 |
5,448.77% |
| P/E |
0.02 - 1.18 |
0.60 |
-43.3% |
| DDM - Stable |
19.31 - 38.65 |
28.98 |
2634.2% |
| DDM - Multi |
0.37 - 0.60 |
0.46 |
-56.4% |
PMCB Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
7.27 |
| Beta |
0.82 |
| Outstanding shares (mil) |
6.86 |
| Enterprise Value (mil) |
-9.11 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.29% |
| Cost of Debt |
5.00% |
| WACC |
6.48% |